Physician profile
Tejas Sheth
NPI 1083901375
$3,120.12
in general payments reported to CMS, 2019-2025
26 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $88.75 · 2021: $349 · 2022: $926 · 2023: $639 · 2024: $347 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,239 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,239.42 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $607.60 | 2019-2025 | Acessa Provu System, Coolseal Generator, Novasure |
| Gynesonics, INC. | $374.34 | 2022 | |
| Exeltis, USA INC. | $354.27 | 2022-2025 | Slynd |
| Abbvie INC. | $341.35 | 2019-2025 | Liletta, Qulipta, Ubrelvy |
| Organon LLC | $283.66 | 2022-2025 | Nexplanon, Jada System |
| Astellas Pharma US INC | $162.51 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $135.52 | 2022-2023 | |
| Coopersurgical, INC. | $96.53 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Exact Sciences Corporation | $83.81 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Alydia Health | $77.96 | 2021 | |
| Merck Sharp & Dohme LLC | $72.16 | 2019-2021 | |
| Allergan, INC. | $68.74 | 2019-2020 | |
| Biogen, INC. | $63.95 | 2025 | Zurzuvae |
| Agile Therapeutics, INC. | $58.69 | 2021-2022 | |
| Becton, Dickinson and Company | $54.32 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $52.15 | 2022 | |
| Channel Medsystems, INC. | $50.93 | 2023 | |
| Lupin INC. | $33.85 | 2019-2021 | |
| Avion Pharmaceuticals | $26.43 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $23.07 | 2024 | |
| Myovant Sciences INC. | $21.59 | 2021 | |
| Meditrina | $20.24 | 2022 | |
| Aesculap, INC. | $17.50 | 2019 | |
| Boston Scientific Corporation | $13.83 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.80 | 2020 | |
| Evofem Biosciences, INC. | $12.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tejas Sheth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.